Ted Wun

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
    Ted Wun
    University of California, Davis Cancer Center, 4501 X St, Ste, 3016, Sacramento, CA, 95817, USA
    J Hematol Oncol 6:17. 2013
  2. doi request reprint Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
    Ted Wun
    Division of Hematology and Oncology, UC Davis School of Medicine, Sacramento, CA 95670, USA
    Thromb Res 125:S96-102. 2010
  3. doi request reprint Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors
    Ted Wun
    Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, California 95187, USA
    Cancer Invest 27:63-74. 2009
  4. doi request reprint Cancer Health Empowerment for Living without Pain (Ca-HELP): effects of a tailored education and coaching intervention on pain and impairment
    Richard L Kravitz
    Department of Internal Medicine and Center for Healthcare Policy and Research, University of California at Davis, Sacramento, CA 95817, USA
    Pain 152:1572-82. 2011
  5. ncbi request reprint Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    Richard H White
    Department of Internal Medicine, University of California, Davis Sacramento, CA, USA
    Thromb Res 120:S29-40. 2007
  6. pmc Exchange transfusion therapy and its effects on real-time microcirculation in pediatric sickle cell anemia patients: an intravital microscopy study
    Anthony T W Cheung
    Department of Medical Pathology, University of California, Davis, CA, USA
    J Pediatr Hematol Oncol 34:169-74. 2012
  7. ncbi request reprint Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
    Thomas J Semrad
    Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California 95817, USA
    J Neurosurg 106:601-8. 2007
  8. pmc Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
    Soames Boyle
    Division of Hematology Oncology, Department of Internal Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Blood 121:4782-90. 2013
  9. doi request reprint The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer
    Rasanamar Sandhu
    Department of Internal Medicine, Division of Hematology Oncology, University of California Davis, Sacramento, California, USA
    Cancer 116:2596-603. 2010
  10. pmc Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
    Grace H Ku
    Division of Hematology and Oncology, School of Medicine, University of California San Diego, CA, USA
    Blood 113:3911-7. 2009

Collaborators

Detail Information

Publications35

  1. pmc A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
    Ted Wun
    University of California, Davis Cancer Center, 4501 X St, Ste, 3016, Sacramento, CA, 95817, USA
    J Hematol Oncol 6:17. 2013
    ..To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we conducted a double-blind, randomized, placebo-controlled study...
  2. doi request reprint Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
    Ted Wun
    Division of Hematology and Oncology, UC Davis School of Medicine, Sacramento, CA 95670, USA
    Thromb Res 125:S96-102. 2010
    ..Primary and secondary pharmacological prophylaxis can be problematic in these patients who are often thrombocytopenic. Strategies to prevent VTE, especially upper extremity catheter-associated thrombosis need to be developed...
  3. doi request reprint Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors
    Ted Wun
    Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, California 95187, USA
    Cancer Invest 27:63-74. 2009
    ..Development of VTE is clearly associated with decreased survival and this effect is greater among patients initially diagnosed with local or regional stage cancer compared to patients with metastatic cancer...
  4. doi request reprint Cancer Health Empowerment for Living without Pain (Ca-HELP): effects of a tailored education and coaching intervention on pain and impairment
    Richard L Kravitz
    Department of Internal Medicine and Center for Healthcare Policy and Research, University of California at Davis, Sacramento, CA 95817, USA
    Pain 152:1572-82. 2011
    ..10). We conclude that TEC, compared with EUC, resulted in improved pain communication self-efficacy and temporary improvement in pain-related impairment, but no improvement in pain severity...
  5. ncbi request reprint Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    Richard H White
    Department of Internal Medicine, University of California, Davis Sacramento, CA, USA
    Thromb Res 120:S29-40. 2007
    ..It is not clear which cancer patients are at highest risk for developing venous thromboembolism (VTE)...
  6. pmc Exchange transfusion therapy and its effects on real-time microcirculation in pediatric sickle cell anemia patients: an intravital microscopy study
    Anthony T W Cheung
    Department of Medical Pathology, University of California, Davis, CA, USA
    J Pediatr Hematol Oncol 34:169-74. 2012
    ..This paradoxical result warrants further investigation on the effects of transfusion volume and viscosity in the exchange transfusion process...
  7. ncbi request reprint Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
    Thomas J Semrad
    Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California 95817, USA
    J Neurosurg 106:601-8. 2007
    ..The authors sought to define the incidence of symptomatic venous thromboembolism (VTE) in patients harboring malignant gliomas...
  8. pmc Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
    Soames Boyle
    Division of Hematology Oncology, Department of Internal Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Blood 121:4782-90. 2013
    ..3 [CI, 2.4-4.6]) and late (HR 1.6 or 3.1, depending on comorbidities). We conclude that ITP patients post splenectomy are at increased risk for AbVTE, VTE, and sepsis...
  9. doi request reprint The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer
    Rasanamar Sandhu
    Department of Internal Medicine, Division of Hematology Oncology, University of California Davis, Sacramento, California, USA
    Cancer 116:2596-603. 2010
    ..The incidence, risk factors, time course, and impact on survival of venous thromboembolism (VTE) in a large, population-based study of patients with bladder cancer have not been identified previously...
  10. pmc Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
    Grace H Ku
    Division of Hematology and Oncology, School of Medicine, University of California San Diego, CA, USA
    Blood 113:3911-7. 2009
    ..In the patients with ALL, development of VTE was associated with a 40% increase in the risk of dying within 1 year. The incidence of VTE in acute leukemia is appreciable, and is comparable with the incidence in many solid tumors...
  11. doi request reprint Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited
    Karen G Chee
    UC Davis Cancer Center, Sacramento, CA 95817, USA
    Arch Intern Med 168:1541-9. 2008
    ..We investigated whether use of highly sensitive positron emission tomography (PET) scanning in non-small cell lung cancer has had this effect...
  12. ncbi request reprint Microvascular abnormalities in sickle cell disease: a computer-assisted intravital microscopy study
    Anthony T W Cheung
    Department of Medical Pathology, University of California UC Davis School of Medicine, Davis, CA 95817, USA
    Blood 99:3999-4005. 2002
    ..The ability to identify and relocate the same conjunctival vessels for longitudinal studies uniquely underscores the applicability of this quantitative real-time technology...
  13. ncbi request reprint Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
    Ted Wun
    Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California 95817, USA
    Cancer 98:1514-20. 2003
    ..The authors performed a retrospective analysis to determine whether there was an increased rate of symptomatic venous thrombosis associated with the use of rHuEpo in patients with carcinoma of the uterine cervix and vagina...
  14. pmc Comparison of real-time microvascular abnormalities in pediatric and adult sickle cell anemia patients
    Anthony T W Cheung
    Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA, USA
    Am J Hematol 85:899-901. 2010
    ..Intervention and effective treatment/management modalities should target pediatric patients to ameliorate, slow down, or prevent progressive microvascular deterioration...
  15. ncbi request reprint Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease
    Ted Wun
    Division of Hematology and Oncology, UC Davis School of Medicine, CA, USA
    Clin Lab Haematol 24:81-8. 2002
    ..3 for African-American controls, and 45.7 +/- 21.6 for patients with SCD (P < 0.001, RM ANOVA; P < 0.05, Newman-Keuls posthoc test). We conclude that there are increased circulating PMAs and monocyte activation in patients with SCD...
  16. doi request reprint A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients
    Imran H Khan
    Center for Comparative Medicine, University of California, Davis, CA 95616, USA
    Cytometry B Clin Cytom 76:159-68. 2009
    ....
  17. ncbi request reprint Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials
    Primo N Lara
    University of California Davis Cancer Center, Sacramento, CA 95817, USA
    J Clin Oncol 23:9282-9. 2005
    ..We evaluated the level of awareness of patients and/or their family members/friends regarding CCTs and SB37...
  18. ncbi request reprint High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
    Carol M Richman
    University of California Davis, Sacramento, California 95817, USA
    Clin Cancer Res 11:5920-7. 2005
    ..In these phase I studies, paclitaxel was combined with radioimmunotherapy in patients with metastatic hormone-refractory prostate cancer or advanced breast cancer...
  19. ncbi request reprint Venous thromboembolism in ovarian cancer
    Anne O Rodriguez
    Department of Obstetrics and Gynecology, University of California Davis, USA
    Gynecol Oncol 105:784-90. 2007
    ..To determine the incidence, time-course, and risk factors associated with the development of thromboembolism (VTE) in a population-based study of women with ovarian cancer...
  20. ncbi request reprint Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival
    Allison Alcalay
    Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA
    J Clin Oncol 24:1112-8. 2006
    ..To describe the incidence and outcomes associated with venous thromboembolism (VTE) among patients with colorectal cancer...
  21. ncbi request reprint Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia
    Kim A Janatpour
    Department of Pathology, University of California, Davis Medical Center, Sacrament, CA 95817, USA
    Am J Clin Pathol 127:429-33. 2007
    ..The sensitivity and NPV of the clinical score was improved by incorporating ELISA results. The combination of a negative ELISA result with low probability 4 Ts resulted in an NPV of 94%...
  22. doi request reprint Risk assessment models for cancer-associated venous thromboembolism
    Mrinal Dutia
    Division of Hematology and Oncology, University of California at Davis School of Medicine, University of California at Davis Medical Center, Sacramento, CA 95817, USA
    Cancer 118:3468-76. 2012
    ....
  23. pmc Epidemiology of cancer-related venous thromboembolism
    Ted Wun
    Division of Hematology and Oncology, Departments of Internal Medicine and Pathology, Clinical and Translational Sciences Center CTSC, University of California, Davis Cancer Center, 4501 X Street, Sacramento, CA 95187, USA
    Best Pract Res Clin Haematol 22:9-23. 2009
    ..Finally, a small percentage of patients with idiopathic VTE and no clinical or laboratory evidence of cancer may harbour an aggressive but 'occult' malignancy likely causally linked to the development of VTE...
  24. pmc Cancer Health Empowerment for Living without Pain (Ca-HELP): study design and rationale for a tailored education and coaching intervention to enhance care of cancer-related pain
    Richard L Kravitz
    Department of Internal Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA
    BMC Cancer 9:319. 2009
    ..Cancer-related pain is common and under-treated. This article describes a study designed to test the effectiveness of a theory-driven, patient-centered coaching intervention to improve cancer pain processes and outcomes...
  25. doi request reprint High variation between hospitals in vena cava filter use for venous thromboembolism
    Richard H White
    Division ofGeneral Medicine, Departmentsof Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA
    JAMA Intern Med 173:506-12. 2013
    ..The extent to which vena cava filter (VCF) use varies between hospitals in the management of acute venous thromboembolism (VTE) is not clear...
  26. pmc Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients
    Mark Levandovsky
    Division of Hematology and Oncology, UC Davis School of Medicine, Sacramento, CA, USA
    J Hematol Oncol 1:23. 2008
    ..We performed a retrospective cohort study of 178 consecutively treated patients with TTP-HUS and analyzed whether clinical or laboratory characteristics could predict for important short- and long-term outcome measures...
  27. ncbi request reprint Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign
    Ari Umutyan
    University of California Davis Cancer Center, Sacramento, California 95817, USA
    Cancer 112:212-9. 2008
    ..The authors assessed willingness to participate in and accrual to CCT...
  28. ncbi request reprint Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment
    Jean Higashida
    Section of Rheumatology, Veterans Affairs, Northern California Health Care System, Sacramento, California, USA
    J Rheumatol 32:2109-15. 2005
    ....
  29. pmc Biomolecular markers of cancer-associated thromboembolism
    Diana L Hanna
    Division of Hematology and Oncology, UC Davis Cancer Center, Sacramento, CA 95817, United States
    Crit Rev Oncol Hematol 88:19-29. 2013
    ..Further studies are needed to optimize these models and determine utility in reducing morbidity and mortality from cancer-associated thromboembolism. ..
  30. ncbi request reprint Inflammatory potential of neutrophils detected in sickle cell disease
    Aaron F H Lum
    Department of Biomedical Engineering, University of California Davis, Davis, California 95616, USA
    Am J Hematol 76:126-33. 2004
    ..These data demonstrate that neutrophils from SCD patients constitutively express active CD18 in blood and respond with enhanced sensitivity to chemokine activation of adhesion, thus increasing their propensity for exuberant adhesion...
  31. ncbi request reprint Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study
    Anthony T W Cheung
    Departmentsof Pathology and Laboratory Medicine, UC Davis School of Medicine, Davis, CA, USA
    J Investig Med 52:402-6. 2004
    ..Further significant improvement induced by poloxamer 188 but not placebo was observed > or = 7 hours postinfusion, resulting in a significant reversal of the microvascular changes to steady-state values...
  32. ncbi request reprint Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk
    William Discepolo
    Department of Medicine, University of California Davis, 95817, USA
    Pathophysiol Haemost Thromb 35:314-21. 2006
    ..On balance, results indicate an effect by Lp(a) on platelet function and future studies focused on specific Lp(a) components, such as the role of apo(a) and of the LDL-like lipid moiety, are needed...
  33. ncbi request reprint SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition
    Primo N Lara
    University of California Davis Cancer Center, Sacramento, California 95817, USA
    Clin Cancer Res 9:4772-81. 2003
    ..Efficacy was correlated with serial plasma VEGF and plasminogen activator inhibitor-1 levels and with positron emission tomography scans...
  34. ncbi request reprint Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin
    Amy Lin
    Department of Internal Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Gynecol Oncol 102:98-102. 2006
    ..We hypothesized that low-dose warfarin would be effective prevention for thromboembolic events in this setting...
  35. ncbi request reprint Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial
    Stephen E Wang
    Division of Hematology and Oncology, Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA
    Am J Hematol 70:191-4. 2002
    ..4% (8/52) in the treatment arm and 15.2% (7/46) in the placebo arm. Premedication prior to transfusion of pre-storage leukocyte reduced SDP does not significantly lower the incidence of NHTR as compared to placebo...